Literature DB >> 3883810

Interactions between adenosine and angiotensin II in controlling glomerular filtration.

J E Hall, J P Granger, R L Hester.   

Abstract

This study examined interactions between adenosine (Ado) and angiotensin II (ANG II) in controlling renal blood flow (RBF) and glomerular filtration rate (GFR). In six normal dogs, intrarenal Ado infusion (1.0 mumol/min) transiently decreased RBF, but during sustained Ado infusion RBF increased to 122 +/- 7% of control, although GFR remained at 75 +/- 6% of control. Blockade of ANG II formation with the converting enzyme inhibitor SQ 14225 (n = 6) almost abolished the transient decrease in RBF but did not prevent the sustained fall in GFR caused by Ado. When circulating ANG II was held constant by intravenous infusion of SQ 14225 and 20 ng . kg-1 . min-1 of ANG II (n = 6), Ado transiently decreased RBF but the return of RBF was much slower than in normal dogs and RBF did not increase above control. Maintenance of constant circulating ANG II did not prevent Ado-mediated decreases in GFR. These observations suggest that Ado-mediated reductions in GFR do not depend entirely on ANG II and may be due to dilation of efferent arterioles by Ado. However, the transient renal vasoconstriction caused by Ado depends on ANG II, and data from this study suggest that part of the waning constrictor response to Ado is due to suppression of renin secretion and endogenous ANG II formation. In circumstances where high ANG II levels are maintained (i.e., ischemic renal failure), Ado may be capable of causing sustained renal vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3883810     DOI: 10.1152/ajprenal.1985.248.3.F340

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Characterization of adenosine receptors in brush-border membranes from pig kidney.

Authors:  J Blanco; E I Canela; J Mallol; C Lluís; R Franco
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

2.  Immunolocalization of ecto-5'-nucleotidase in the kidney by a monoclonal antibody.

Authors:  R Gandhi; M Le Hir; B Kaissling
Journal:  Histochemistry       Date:  1990

3.  Adenosine modulates vasomotor tone in outer medullary descending vasa recta of the rat.

Authors:  E P Silldorff; M S Kreisberg; T L Pallone
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 4.  Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice.

Authors:  Jurgen Schnermann; Josephine P Briggs
Journal:  Kidney Int       Date:  2008-04-16       Impact factor: 10.612

5.  Adenosine A1-receptor knockout mice have a decreased blood pressure response to low-dose ANG II infusion.

Authors:  Dexter L Lee; Tracy D Bell; Jenny Bhupatkar; Glenn Solis; William J Welch
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-08       Impact factor: 3.619

6.  P2-, but not P1-purinoceptors mediate formation of 1, 4, 5-inositol trisphosphate and its metabolites via a pertussis toxin-insensitive pathway in the rat renal cortex.

Authors:  C Nanoff; M Freissmuth; E Tuisl; W Schütz
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

7.  Renal haemodynamic responses to exogenous and endogenous adenosine in conscious dogs.

Authors:  H Berthold; A Just; H R Kirchheim; H Osswald; H Ehmke
Journal:  J Physiol       Date:  1998-07-01       Impact factor: 5.182

8.  Effect of adenosine and adenosine analogues on cyclic AMP accumulation in cultured mesangial cells and isolated glomeruli of the rat.

Authors:  A Olivera; J M Lopez-Novoa
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

9.  Further characterization of the renovascular effects of N6-cyclohexyladenosine in the isolated perfused rat kidney.

Authors:  N F Rossi; P C Churchill; K A Jacobson; A E Leahy
Journal:  J Pharmacol Exp Ther       Date:  1987-03       Impact factor: 4.030

10.  Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.

Authors:  Daniela Patinha; Angelica Fasching; Dora Pinho; António Albino-Teixeira; Manuela Morato; Fredrik Palm
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.